Research and development- AOI #16+ seeking to manufacture and obtain regulatory approval for the cytotracker BV, a point-of-care instant white blood cell analysis platform for discriminating between…
Active Definitive Contract Awarded Last action
- Contract number
- 75A50123C00028
- Awardee
-
Rizlab Health Inc. UEI H75CJVCZZNP3
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $2,483,472
Award facts
- Opportunity
-
- EZBAA22100SOL00003 Solicitation number
- Contract value 100% obligated
- $2,483,472.00 Current and potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Princeton, NJ, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,483,472 |
About this award
Rizlab Health Inc. has been awarded a $2.48 million firm fixed-price contract by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to research, develop, and obtain regulatory approval for the Cytotracker BV, a point-of-care diagnostic platform designed to rapidly discriminate between acute viral and bacterial infections through instant white blood cell analysis. The contract, awarded on August 11, 2023, with an ultimate completion date of April 10, 2027, will be performed in Princeton, New Jersey. No set-aside designation was used for this procurement, which represents a continuation of the government's investment in rapid diagnostic technologies for infectious disease detection and stratification.
Rizlab Health Inc. is an established provider of innovative medical diagnostic technologies with demonstrated expertise in developing point-of-care platforms for rapid infection detection. The company's prior federal contracts include a $74,959 Small Business Innovation Research award from the Air Force for a wireless portable hematology analyzer and a $741,000 HHS contract for a data-driven home monitoring system for infection classification. Additionally, Rizlab has received grants from the National Science Foundation and collaborated on NASA-funded research in portable hematology and wearable blood count analysis. This contract award leverages the company's established capabilities in microfluidics and biosensor technologies to advance diagnostic solutions with direct applications to healthcare preparedness and response initiatives.
Description
Research and development- AOI #16+ seeking to manufacture and obtain regulatory approval for the cytotracker BV, a point-of-care instant white blood cell analysis platform for discriminating between acute viral and bacterial infections.
Quick answers
Who was awarded contract 75A50123C00028?
75A50123C00028 was awarded to Rizlab Health Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 11, 2023.
How much is contract 75A50123C00028 worth?
The government has obligated $2,483,472 on 75A50123C00028.
Was contract 75A50123C00028 competed?
The extent of competition for 75A50123C00028 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award